Biology Reference
In-Depth Information
References
[1] Xun CQ, Thompson JS, Jennings CD, Brown SA, Widmer MB. Effect of total body irradi-
ation, busulfan-cyclophosphamide, or cyclophosphamide conditioning on inflamma-
tory cytokine release and development of acute and chronic graft-versus-host disease
in H-2-incompatible transplanted SCID mice. Blood 1994;83(8):2360-7.
[2] Hill GR, Crawford JM, Cooke KR, Brinson YS, Pan L, Ferrara JL. Total body irradiation
and acute graft-versus-host disease: the role of gastrointestinal damage and inflamma-
tory cytokines. Blood 1997;90(8):3204-13.
[3] Teshima T, Ordemann R, Reddy P, Gagin S, Liu C, Cooke KR, et al. Acute graft-versus-
host disease does not require alloantigen expression on host epithelium. Nat Med
2002;8(6):575-81.
[4] Beutler B. Inferences, questions and possibilities in Toll-like receptor signalling. Nature
2004;430(6996):257-63.
[5] Burman AC, Banovic T, Kuns RD, Clouston AD, Stanley AC, Morris ES, et al. IFNgamma
differentially controls the development of idiopathic pneumonia syndrome and GVHD
of the gastrointestinal tract. Blood 2007;110(3):1064-72.
[6] Yu Y, Wang D, Liu C, Kaosaard K, Semple K, Anasetti C, et al. Prevention of GVHD while
sparing GVL effect by targeting Th1 and Th17 transcription factor T-bet and RORγt in
mice. Blood 2011;118(18):5011-20.
[7] Bleakley M, Riddell SR. Molecules and mechanisms of the graft-versus-leukaemia ef-
fect. Nat Rev Cancer 2004;4(5):371-80.
[8] Lowdell MW. Natural killer cells in haematopoietic stem cell transplantation. Transfus
Med 2003;13(6):399-404.
[9] Pan L, Teshima T, Hill GR, Bungard D, Brinson YS, Reddy VS, et al. Granulocyte
colony-stimulating factor-mobilized allogeneic stem cell transplantation maintains
graft-versus-leukemia effects through a perforin-dependent pathway while preventing
graft-versus-host disease. Blood 1999;93:4071-8.
[10] Schmaltz C, Alpdogan O, Kappel BJ, Muriglan SJ, Rotolo JA, Ongchin J, et al. T cells
require TRAIL for optimal graft-versus-tumor activity. Nat Med 2002;8(12):1433-7.
[11] Hill GR, Teshima T, Gerbita A, Pan L, Cooke KR, Brinson YS, et al. Differential roles of
IL-1 and TNFα on graft-versus-host disease and graft-versus leukemia. J Clin Invest
1999;104:459-67.
[12] Meraz MA, White JM, Sheehan KC, Bach EA, Rodig SJ, Dighe AS, et al. Targeted disrup-
tion of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-
STAT signaling pathway. Cell 1996;84(3):431-42.
[13] Nestel FP, Price KS, Seemayer TA, Lapp WS. Macrophage priming and lipopolysaccha-
ride-triggered release of tumor necrosis factor alpha during graft-versus-host disease. J
Exp Med 1992;175(2):405-13.
[14] Capitini CM, Herby S, Milliron M, Anver MR, Mackall CL, Fry TJ. Bone marrow deficient
in IFN-γ signaling selectively reverses GVHD-associated immunosuppression and
enhances a tumor-specific GVT effect. Blood 2009;113(20):5002-9.
[15] Markey KA, Koyama M, Kuns RD, Lineburg KE, Wilson YA, Olver SD, et al. Immune in-
sufficiency during GVHD is due to defective antigen presentation within dendritic cell
subsets. Blood 2012;119:5918-30.
[16] Yi T, Chen Y, Wang L, Du G, Huang D, Zhao D, et al. Reciprocal differentiation and
tissue-specific pathogenesis of Th1, Th2, and Th17 cells in graft-versus-host disease.
Blood 2009;114(14):3101-12.
[17] Mowat AM. Antibodies to IFN-gamma prevent immunologically mediated intestinal
damage in murine graft-versus-host reaction. Immunology 1989;68(1):18-23.
[18] Garside P, Reid S, Steel M, Mowat AM. Differential cytokine production associated with
distinct phases of murine graft-versus-host reaction. Immunology 1994;82(2):211-4.
[19] Yang YG, Qi J, Wang MG, Sykes M. Donor-derived interferon gamma separates graft-
versus-leukemia effects and graft-versus-host disease induced by donor CD8 T cells.
Blood 2002;99(11):4207-15.
[20] Yang Y, Wang H, Yu H, Yeap BY, Liang T, Wang G, et al. IFN-gamma promotes graft-
versus-leukemia effects without directly interacting with leukemia cells in mice after
allogeneic hematopoietic cell transplantation. Blood 2011;118(13):3721-4.
[21] de Weerd NA, Samarajiwa SA, Hertzog PJ. Type I interferon receptors: biochemistry and
biological functions. J Biol Chem 2007;282(28):20053-7.
[22] Pestka S, Krause CD, Walter MR. Interferons, interferon-like cytokines, and their recep-
tors. Immunol Rev 2004;202:8-32.
[23] Gilliet M, Cao W, Liu YJ. Plasmacytoid dendritic cells: sensing nucleic acids in viral
infection and autoimmune diseases. Nat Rev Immunol 2008;8(8):594-606.
382
Search WWH ::
Custom Search